Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation

NCT06935890 is registered in ClinicalTrials.gov with Murdoch Childrens Research Institute as lead sponsor.

NCT NCT06935890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Lead sponsor
Murdoch Childrens Research Institute
Phase
Phase 4
Overall status
Recruiting
Start date
November 25, 2025
Completion date
October 31, 2029
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, immunotherapy, venom allergy